ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Clinigen and Mitsubishi Tanabe Initiate European Managed Access Program for Edaravone to Treat ALS
June 04, 2018Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has partnered with Mitsubishi Tanabe Pharma Corporation (‘MTPC’), to initiate a Managed Access Program (also known as an Early Access Program) in Europe for edarav -
Clinigen, Mitsubishi link for early access programme
May 24, 2018ALS is an idiopathic neurodegenerative disease in which motor neurons selectively degenerate and vanish, affecting around two in 100,000 people worldwide. -
Clinigen and Mitsubishi Tanabe Initiate European Managed Access Program for Edaravone to Treat ALS
May 23, 2018the global pharmaceutical and services company, has partnered with Mitsubishi Tanabe Pharma Corporation (‘MTPC’),
Pharma Sources Insight January 2025
